BSX
BOSTON SCIENTIFIC CORP
$46.91
-0.55%
$69.7B
No data for this timeframe.
Vol
Market Cap$69.7B
Cap SizeLarge Cap
Analyst ConsensusStrong Buy (80%)
Inst. Holders50 funds
Inst. Value$51.4B
Inst. Activity32 buys / 18 sells
Insider Activity4B / 0S
Insider Net $$554.0K
Reddit Sentiment57° Neutral
SEC Reports5
Congressional6 trades
Exchange NYSE·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0000885725·Prev Close $47.17
Recent Activity
May 28, 2026
Insider
Mahoney Michael F gifted 386,755 shares
Chairman, President & CEO
May 21, 2026
SEC
Three directors purchased ~$554K of BSX stock in open-market transactions over two days. While a cluster of insider buyi
CLUSTER — Impact 3/10
May 20, 2026
Insider
Habiger David C bought 2,250 shares
Director @ $55.92 ($125.8K)
May 20, 2026
Insider
Pegus Cheryl bought 1,770 shares
Director @ $56.49 ($100.0K)
May 18, 2026
SEC
Boston Scientific entered into a $2B accelerated share repurchase (ASR) agreement with JPMorgan to repurchase its common
8-K — Impact 4/10
May 18, 2026
SEC
Boston Scientific invested $1.5 billion for a 33.75% equity stake in MiRus LLC, a privately-held developer of the SIEGEL
8-K — Impact 7/10
Inst.
WEALTH ENHANCEMENT ADVISORY SERVICES, — ADD
179,724 shares (—)
Inst.
WELLINGTON MANAGEMENT GROUP LLP — ADD
18,833,406 shares ($1.2B)
Price Targets
$77.10
+64.4% upside
Strong Buy
Current $46.91
Low $55.00
Median $75.50
High $106.00
30 analysts
$55.00
$106.00
Analyst Ratings
12Strong Buy
20Buy
8Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 4, 2026 | Truist Securities | MAINTAIN | Buy → Buy |
| Jun 3, 2026 | BTIG | MAINTAIN | Buy → Buy |
| Jun 1, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| May 29, 2026 | Wolfe Research | DOWNGRADE | Outperform → Peer Perform |
| May 28, 2026 | Citigroup | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.83 | $0.81 — $0.84 | 11% YoY | 24 |
| Next Q | $0.84 ▼ -0.6% | $0.82 — $0.87 | 12% YoY | 23 |
| Current FY | $3.36 | $3.32 — $3.42 | 10% YoY | 28 |
| Next FY | $3.72 ▼ -1.0% | $3.60 — $3.90 | 11% YoY | 29 |
Latest Reports
NEUTRAL
CLUSTER
3/10
Three directors purchased ~$554K of BSX stock in open-market transactions over two days. While a cluster of insider buyi
May 21, 2026
NEUTRAL
8-K
4/10
Boston Scientific entered into a $2B accelerated share repurchase (ASR) agreement with JPMorgan to repurchase its common
May 18, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| WEALTH ENHANCEMENT ADVISORY SERVICES, | — | ADD |
| BlackRock, Inc. | $8.3B | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.0B | — |
| FMR LLC | $4.7B | — |
| STATE STREET CORP | $4.3B | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 28, 2026 | Mahoney Michael | G | $0.00 |
| May 20, 2026 | Habiger David | BUY | $125.8K |
| May 20, 2026 | Pegus Cheryl | BUY | $100.0K |
| May 20, 2026 | LUDWIG EDWARD | BUY | $202.9K |
| May 19, 2026 | Habiger David | BUY | $125.3K |
Reddit Sentiment
57°
Neutral
Bearish
Neutral
Bullish
Congressional Trades
5 members: 5 buys, 1 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| Ro Khanna | D | BUY | $15,001 - $50,000 |
| Michael McCaul | R | BUY | $1,001 - $15,000 |
| Gilbert Cisneros | D | BUY | $1,001 - $15,000 |
50 institutional holders with $51.4B total value (818,233,177 shares) as of 2026-Q1. Top holders: WEALTH, BlackRock,, VANGUARD. Net buying activity: 32 institutions added/increased vs 18 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 179,724 | $0.00 | 0.0% | ADD +32.7% |
| 2 | BlackRock, Inc. | 131,822,037 | $8.3B | 16.1% | — |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 96,411,568 | $6.0B | 11.8% | — |
| 4 | FMR LLC | 74,226,395 | $4.7B | 9.1% | — |
| 5 | STATE STREET CORP | 67,986,847 | $4.3B | 8.3% | — |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 29,796,211 | $1.9B | 3.6% | — |
| 7 | D. E. Shaw & Co., Inc. | 24,312,352 | $1.5B | 3.0% | — |
| 8 | BANK OF AMERICA CORP /DE/ | 22,756,646 | $1.4B | 2.8% | — |
| 9 | MORGAN STANLEY | 22,266,664 | $1.4B | 2.7% | — |
| 10 | GOLDMAN SACHS GROUP INC | 18,891,624 | $1.2B | 2.3% | — |
| 11 | WELLINGTON MANAGEMENT GROUP LLP | 18,833,406 | $1.2B | 2.3% | ADD +94.0% |
| 12 | JANUS HENDERSON GROUP PLC | 16,497,366 | $1.0B | 2.0% | ADD +31.0% |
| 13 | Capital World Investors | 15,309,738 | $960.7M | 1.9% | TRIM -43.6% |
| 14 | FRANKLIN RESOURCES INC | 14,498,741 | $909.8M | 1.8% | DOUBLED +155.4% |
| 15 | Amundi | 14,122,913 | $886.2M | 1.7% | — |
| 16 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 13,891,668 | $871.7M | 1.7% | ADD +25.9% |
| 17 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13,229,644 | $830.2M | 1.6% | TRIM -28.6% |
| 18 | Nuveen, LLC | 11,734,314 | $736.3M | 1.4% | ADD +25.2% |
| 19 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10,996,572 | $716.9M | 1.4% | — |
| 20 | Legal & General Group Plc | 10,600,766 | $665.2M | 1.3% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | ADD | 135,485 | 179,724 | +32.7% | — | 2026-Q1 |
| WELLINGTON MANAGEMENT GROUP LLP | ADD | 9,709,089 | 18,833,406 | +94.0% | $1.2B | 2026-Q1 |
| JANUS HENDERSON GROUP PLC | ADD | 12,589,385 | 16,497,366 | +31.0% | $1.0B | 2026-Q1 |
| Capital World Investors | TRIM | 27,151,575 | 15,309,738 | -43.6% | $960.7M | 2026-Q1 |
| FRANKLIN RESOURCES INC | DOUBLED | 5,676,082 | 14,498,741 | +155.4% | $909.8M | 2026-Q1 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | 11,035,628 | 13,891,668 | +25.9% | $871.7M | 2026-Q1 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | TRIM | 18,540,693 | 13,229,644 | -28.6% | $830.2M | 2026-Q1 |
| Nuveen, LLC | ADD | 9,372,294 | 11,734,314 | +25.2% | $736.3M | 2026-Q1 |
| Assenagon Asset Management S.A. | DOUBLED | 4,306,176 | 10,057,936 | +133.6% | $631.1M | 2026-Q1 |
| Invesco Ltd. | TRIM | 13,318,177 | 9,051,941 | -32.0% | $568.0M | 2026-Q1 |
| Ninety One UK Ltd | ADD | 5,444,549 | 7,308,540 | +34.2% | $458.6M | 2026-Q1 |
| 1832 Asset Management L.P. | DOUBLED | 2,201,658 | 7,252,746 | +229.4% | $455.1M | 2026-Q1 |
| Neuberger Berman Group LLC | ADD | 4,010,261 | 7,072,894 | +76.4% | $443.8M | 2026-Q1 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | DOUBLED | 2,082,360 | 4,633,237 | +122.5% | $290.7M | 2026-Q1 |
| Point72 Asset Management, L.P. | ADD | 2,434,563 | 3,687,315 | +51.5% | $231.4M | 2026-Q1 |
| FIL Ltd | TRIM | 4,758,079 | 3,214,116 | -32.4% | $201.7M | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 2,382,705 | 3,152,005 | +32.3% | $197.8M | 2026-Q1 |
| Unisphere Establishment | ADD | 2,176,700 | 2,802,700 | +28.8% | $175.9M | 2026-Q1 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | DOUBLED | 1,028,376 | 2,629,613 | +155.7% | $165.0M | 2026-Q1 |
| Mariner, LLC | DOUBLED | 431,206 | 2,484,960 | +476.3% | $155.9M | 2026-Q1 |
| Clearbridge Investments, LLC | DOUBLED | 733,237 | 2,279,418 | +210.9% | $143.0M | 2026-Q1 |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | ADD | 1,416,308 | 2,077,623 | +46.7% | $130.4M | 2026-Q1 |
| ENVESTNET ASSET MANAGEMENT INC | TRIM | 2,607,040 | 1,686,819 | -35.3% | $105.8M | 2026-Q1 |
| CAPITAL FUND MANAGEMENT S.A. | ADD | 1,152,048 | 1,665,947 | +44.6% | $104.5M | 2026-Q1 |
| Phoenix Financial Ltd. | DOUBLED | 64,968 | 1,550,372 | +2286.4% | $97.3M | 2026-Q1 |
17 unique insiders with 50 transactions. Net insider value: $554.0K ($554.0K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 28, 2026 | Mahoney Michael F | Chairman, President & CEO | GIFT | 386,755 | — | — |
| May 20, 2026 | Habiger David C | Director | BUY | 2,250 | $55.92 | $125.8K |
| May 20, 2026 | Pegus Cheryl | Director | BUY | 1,770 | $56.49 | $100.0K |
| May 20, 2026 | LUDWIG EDWARD J | Director | BUY | 3,580 | $56.68 | $202.9K |
| May 19, 2026 | Habiger David C | Director | BUY | 2,200 | $56.95 | $125.3K |
| May 7, 2026 | LUDWIG EDWARD J | Director | AWARD | 3,800 | — | — |
| May 7, 2026 | Habiger David C | Director | AWARD | 3,800 | — | — |
| May 7, 2026 | Pegus Cheryl | Director | AWARD | 3,800 | — | — |
| May 7, 2026 | Mega Jessica L | Director | AWARD | 3,800 | — | — |
| May 7, 2026 | Morano Susan E | Director | AWARD | 3,800 | — | — |
| May 7, 2026 | Zane Ellen M | Director | AWARD | 3,800 | — | — |
| May 7, 2026 | WICHMANN DAVID S | Director | AWARD | 3,800 | — | — |
| May 7, 2026 | Weber Christophe Pierre | Director | AWARD | 1,767 | — | — |
| May 7, 2026 | Weber Christophe Pierre | Director | AWARD | 2,660 | — | — |
| May 7, 2026 | Smith Cathy R | Director | AWARD | 3,800 | — | — |
| May 2, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | EXERCISE | 2,102 | — | — |
| May 2, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | TAX W/H | 1,007 | $56.50 | $56.9K |
| May 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | EXERCISE | 1,802 | — | — |
| May 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | TAX W/H | 872 | $56.50 | $49.3K |
| Mar 2, 2026 | Morano Susan E | Director | AWARD | 24 | — | — |
| Mar 2, 2026 | Pegus Cheryl | Director | AWARD | 24 | — | — |
| Mar 2, 2026 | Weber Christophe Pierre | Director | AWARD | 556 | — | — |
| Mar 1, 2026 | Woodworth Emily | SVP, Global Controller and CAO | EXERCISE | 838 | — | — |
| Feb 19, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | I | 6,851 | $75.76 | $519.0K |
| Feb 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | AWARD | 11,143 | — | — |
| Feb 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | AWARD | 4,722 | — | — |
| Feb 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | TAX W/H | 338 | $74.12 | $25.1K |
| Feb 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | EXERCISE | 961 | — | — |
| Feb 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | AWARD | 35,817 | — | — |
| Feb 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | AWARD | 15,178 | — | — |
| Feb 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | TAX W/H | 1,302 | $74.12 | $96.5K |
| Feb 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | EXERCISE | 2,692 | — | — |
| Feb 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | AWARD | 17,510 | — | — |
| Feb 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | AWARD | 7,420 | — | — |
| Feb 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | TAX W/H | 488 | $74.12 | $36.2K |
| Feb 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | EXERCISE | 1,442 | — | — |
| Feb 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | AWARD | 43,776 | — | — |
| Feb 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | AWARD | 18,550 | — | — |
| Feb 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | TAX W/H | 1,612 | $74.12 | $119.5K |
| Feb 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | EXERCISE | 3,462 | — | — |
| Feb 12, 2026 | Monson Jonathan | EVP and CFO | AWARD | 27,857 | — | — |
| Feb 12, 2026 | Monson Jonathan | EVP and CFO | AWARD | 11,805 | — | — |
| Feb 12, 2026 | Monson Jonathan | EVP and CFO | TAX W/H | 573 | $74.12 | $42.5K |
| Feb 12, 2026 | Monson Jonathan | EVP and CFO | EXERCISE | 1,154 | — | — |
| Feb 12, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | AWARD | 11,939 | — | — |
| Feb 12, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | AWARD | 5,059 | — | — |
| Feb 12, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | TAX W/H | 457 | $74.12 | $33.9K |
| Feb 12, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | EXERCISE | 1,058 | — | — |
| Feb 12, 2026 | Mahoney Michael F | Chairman, President & CEO | AWARD | 131,329 | — | — |
| Feb 12, 2026 | Mahoney Michael F | Chairman, President & CEO | AWARD | 55,652 | — | — |
5 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 4.8/10.
NEUTRAL
CLUSTER
3/10
Three directors purchased ~$554K of BSX stock in open-market transactions over two days. While a clu
May 21, 2026
NEUTRAL
8-K
4/10
Boston Scientific entered into a $2B accelerated share repurchase (ASR) agreement with JPMorgan to r
May 18, 2026
BULLISH
8-K
7/10
Boston Scientific invested $1.5 billion for a 33.75% equity stake in MiRus LLC, a privately-held dev
May 18, 2026
NEUTRAL
DEFA14A
3/10
Analysis based on filing metadata only — document content was unavailable. This DEFA14A filing by Bo
Mar 18, 2026
BULLISH
INST-CLUSTER
7/10
Three major institutions — Norges Bank, Mawer Investment Management, and Renaissance Technologies —
Feb 28, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (80% buy). Based on 40 analysts: 12 strong buy, 20 buy, 8 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$77.10 mean target
+64.4% upside
Strong Buy (1.48)
$55.00 Low
$106.00 High
| Metric | Value |
|---|---|
| Current Price | $46.91 |
| Target Low | $55.00 |
| Target Mean | $77.10 |
| Target Median | $75.50 |
| Target High | $106.00 |
| # Analysts | 30 |
| Recommendation | Strong Buy (1.48) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.83 | $0.81 | $0.84 | 10.5% | -0.4% | 1↑ 8↓ | $5.4B | 6.2% | 24 |
| Next Q 2026-09-30 |
$0.84 | $0.82 | $0.87 | 12.0% | -0.6% | 1↑ 10↓ | $5.4B | 6.2% | 23 |
| Current FY 2026-12-31 |
$3.36 | $3.32 | $3.42 | 10.0% | -0.4% | 1↑ 13↓ | $21.6B | 7.6% | 28 |
| Next FY 2027-12-31 |
$3.72 | $3.60 | $3.90 | 10.7% | -1.0% | 1↑ 14↓ | $23.4B | 8.2% | 29 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.829 | |
| 7d ago | $0.830 | -0.000 |
| 30d ago | $0.832 | -0.003 |
| 60d ago | $0.864 | -0.035 |
| 90d ago | $0.867 | -0.038 |
22 analyst firms have rated this stock: 0 upgrades, 3 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 4, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Jun 3, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Jun 1, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| May 29, 2026 | Wolfe Research | DOWNGRADE | Outperform | Peer Perform |
| May 28, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| May 28, 2026 | Leerink Partners | MAINTAIN | Outperform | Outperform |
| May 28, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| May 28, 2026 | Wells Fargo | DOWNGRADE | Overweight | Equal-Weight |
| May 19, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| May 18, 2026 | B of A Securities | MAINTAIN | Buy | Buy |
| May 18, 2026 | Needham | REITERATE | Buy | Buy |
| May 18, 2026 | BTIG | REITERATE | Buy | Buy |
| Apr 23, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Apr 23, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Apr 23, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 23, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Apr 23, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Apr 23, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Apr 23, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| Apr 23, 2026 | Goldman Sachs | MAINTAIN | Buy | Buy |
| Apr 23, 2026 | Needham | MAINTAIN | Buy | Buy |
| Apr 22, 2026 | Jefferies | MAINTAIN | Buy | Buy |
| Apr 22, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 22, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Apr 21, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Apr 15, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Apr 13, 2026 | Mizuho | MAINTAIN | Outperform | Outperform |
| Apr 7, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Mar 30, 2026 | RBC Capital | REITERATE | Outperform | Outperform |
| Mar 30, 2026 | Raymond James | DOWNGRADE | Strong Buy | Outperform |
| Mar 30, 2026 | Needham | REITERATE | Buy | Buy |
| Mar 27, 2026 | Goldman Sachs | MAINTAIN | Buy | Buy |
| Mar 20, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Mar 20, 2026 | Needham | REITERATE | Buy | Buy |
| Mar 18, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Mar 17, 2026 | UBS | MAINTAIN | Buy | Buy |
| Mar 11, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Feb 17, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Feb 9, 2026 | BTIG | REITERATE | Buy | Buy |
| Feb 5, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Feb 5, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Feb 5, 2026 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Feb 5, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Feb 5, 2026 | UBS | MAINTAIN | Buy | Buy |
| Feb 5, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Feb 5, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Feb 5, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Feb 5, 2026 | Morgan Stanley | MAINTAIN | Overweight | Overweight |
| Feb 5, 2026 | Stifel | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 12 | 20 | 8 | 0 | 0 | 80% | |
| May 1, 2026 | 13 | 23 | 5 | 0 | 0 | 88% | |
| Apr 1, 2026 | 13 | 25 | 3 | 0 | 0 | 93% | |
| Mar 1, 2026 | 14 | 23 | 3 | 0 | 0 | 93% | |
| Feb 1, 2026 | 15 | 22 | 3 | 0 | 0 | 93% | |
| Jan 1, 2026 | 15 | 21 | 4 | 0 | 0 | 90% |
Strong BuyBuyHoldSellStrong Sell
5 members of Congress traded this stock: 5 buys, 1 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | Ro Khanna | D | HOUSE | BUY | $15,001 - $50,000 | Boston Scientific Corp | Apr 9, 2026 (11d) |
| Mar 27, 2026 | Michael McCaul | R | HOUSE | BUY | $1,001 - $15,000 | Boston Scientific Corp | Apr 10, 2026 (15d) |
| Feb 10, 2026 | Gilbert Cisneros | D | HOUSE | BUY | $1,001 - $15,000 | Boston Scientific Corp | Mar 10, 2026 (29d) |
| Jan 30, 2026 | Gilbert Cisneros | D | HOUSE | BUY | $1,001 - $15,000 | Boston Scientific Corp | Feb 16, 2026 (18d) |
| Dec 29, 2025 | Markwayne Mullin | R | SENATE | BUY | $15,001 - $50,000 | Boston Scientific Corp | Jan 16, 2026 (19d) |
| Dec 17, 2025 | John Boozman | R | SENATE | SELL | $1,001 - $15,000 | Boston Scientific Corp | Jan 13, 2026 (28d) |
57°
Neutral
Bearish
Neutral
Bullish
3 mentions
2 bullish
1 bearish
3 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 28, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Apr 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Will Medtronic be punished like BSX was?
▲ 1
💬 1
⚡ 0.5
May 18, 2026
dark_pool
Dark Pool: BSX — 18.3M shares, 197,075 trades
Week starting 2026-05-18. Total ATS volume: 18,257,221 shares across 197,075 trades.
May 13, 2026
short_interest
FTD: BSX — 21,439 shares ($1.2M) failed to deliver
Settlement: 20260513, Price: $54.10, FTD Value: $1,159,849.9, BOSTON SCIENTIFIC CORP
May 11, 2026
dark_pool
Dark Pool: BSX — 20.4M shares, 207,129 trades
Week starting 2026-05-11. Total ATS volume: 20,394,228 shares across 207,129 trades.
May 8, 2026
short_interest
FTD: BSX — 8,866 shares ($0.5M) failed to deliver
Settlement: 20260508, Price: $56.57, FTD Value: $501,549.62, BOSTON SCIENTIFIC CORP
May 5, 2026
short_interest
FTD: BSX — 39,690 shares ($2.3M) failed to deliver
Settlement: 20260505, Price: $56.85, FTD Value: $2,256,376.5, BOSTON SCIENTIFIC CORP
May 4, 2026
dark_pool
Dark Pool: BSX — 23.9M shares, 211,526 trades
Week starting 2026-05-04. Total ATS volume: 23,891,732 shares across 211,526 trades.
May 1, 2026
short_interest
FTD: BSX — 177,348 shares ($10.2M) failed to deliver
Settlement: 20260501, Price: $57.61, FTD Value: $10,217,018.28, BOSTON SCIENTIFIC CORP
Apr 27, 2026
dark_pool
Dark Pool: BSX — 24.3M shares, 229,523 trades
Week starting 2026-04-27. Total ATS volume: 24,279,150 shares across 229,523 trades.
Apr 22, 2026
earnings_calendar
BSX Q1 2026 Earnings Before Market Open — 2026-04-22
Apr 20, 2026
short_interest
FTD: BSX — 24,279 shares ($1.6M) failed to deliver
Settlement: 20260420, Price: $64.23, FTD Value: $1,559,440.17, BOSTON SCIENTIFIC CORP
Apr 20, 2026
dark_pool
Dark Pool: BSX — 38.6M shares, 325,556 trades
Week starting 2026-04-20. Total ATS volume: 38,597,185 shares across 325,556 trades.
Apr 13, 2026
dark_pool
Dark Pool: BSX — 14.9M shares, 149,938 trades
Week starting 2026-04-13. Total ATS volume: 14,941,332 shares across 149,938 trades.
Apr 6, 2026
dark_pool
Dark Pool: BSX — 21.4M shares, 184,925 trades
Week starting 2026-04-06. Total ATS volume: 21,416,259 shares across 184,925 trades.
Mar 30, 2026
dark_pool
Dark Pool: BSX — 32.2M shares, 278,600 trades
Week starting 2026-03-30. Total ATS volume: 32,155,827 shares across 278,600 trades.
Mar 23, 2026
dark_pool
Dark Pool: BSX — 16.0M shares, 181,662 trades
Week starting 2026-03-23. Total ATS volume: 15,984,247 shares across 181,662 trades.